Outpatient care for pregnant and puerperal women during the COVID-19 pandemic

Key-points

• The COVID-19 pandemic remains a rapidly evolving situation, and as new research and data become available, clinical care recommendations should be refined to reflect the most current information.

• Importance of maintaining outpatient care for pregnant and postpartum women during the pandemic period due to the new coronavirus

• Provide care so that consultations do not become a place of risk for contamination of users and health professionals. This care must involve the physical space, use of PPE, guidance from professionals and pregnant and postpartum women

• Importance of vaccination of pregnant women for influenza, thus facilitating the differential diagnosis of respiratory syndromes

• Provide strategies for health education in prenatal care and postpartum care using new technologies

• The more expanded the testing for COVID-19, the more it provides protection for professionals and patients

The National Specialty Commission for Prenatal Care of the Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO) endorses to this document. The content production is based on scientific studies on a thematic proposal and the findings presented contribute to clinical practice.

Publikationsverlauf

Artikel online veröffentlicht:
29. September 2020

• References

• 1 Rolling updates on coronavirus disease (COVID-19): WHO characterizes COVID-19 as a pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
• 2 WHO recommendations on antenatal care for a positive pregnancy experience, 2016. https://apps.who.int/iris/bitstream/handle/10665/250796/9789241549912-eng.pdf;jsessionid=E15FAE016E07E0B15DB6D0D5223BB51D?sequence=1
• 3 Rasmussen SA. , et al. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol. 2012; . Sep;207(3 Suppl): S3-8 DOI: 10.1016/j.ajog.2012.06.068.
• 4 Mosby LG, Ellington SR, Forhan SE, Yeung LF, Perez M, Shah MM, MacFarlane K, Laird SK, House LD, Jamieson DJ. The Centers for Disease Control and Prevention's maternal health response to 2009 H1N1 influenza. Am J Obstet Gynecol. 2011; Jun;204204(6 Suppl 1): S7-12 DOI: 10.1016/j.ajog.2011.02.057.
• 5 Takemoto MLS, Menezes MO, Andreucci CB, Nakamura-Pereira M, Amorim MMR, Katz L, Knobel R. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int J Gynaecol Obstet. 2020; Jul 9 DOI: 10.1002/ijgo.13300.
• 6 ACOG - Novel Coronavirus 2019 (COVID 19). Practice Advisory. July 2020 https://www.acog.org/en/Clinical/Clinical%20Guidance/Practice%20Advisory/Articles/2020/03/Novel%20Coronavirus%202019 . Access 07.06.2020
• 7 Lambelet V, Vouga M, Pomar L, Favre G, Gerbier E, Panchaud A, Baud D. Sars-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care. Prenat Diagn. 2020 May 26:10.1002/pd.5759. doi: 10.1002/pd.5759. Online ahead of print
• 8 -Safe motherhood and COVID-19 https://www.figo.org/safe-motherhood-and-covid-19
• 9 ORIENTAÇÕES GERAIS – Máscaras faciais de uso não profissional – NT Anvisa http://portal.anvisa.gov.br/documents/219201/4340788/NT+M%C3%A1scaras.pdf/bf430184-8550-42cb-a975-1d5e1c5a10f
• 10 Bourne T, Leonardi M, Kyriacou C, Al-Memar M, Landolfo C, Cibula D, Condous G, Metzger U, Fischerova D, Timmerman D. , van den Bosch. ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2. Ultrasound Obstet Gynecol. 2020; Jun; 55 (06) 879-885 DOI: 10.1002/uog.22047.
• 11 COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics https://www.acog.org/clinical-information/physician-faqs/covid-19-faqs-for-ob-gyns-obstetrics
• 12 European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19 https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19
• 13 Sutton D¹, Fuchs K¹, D'Alton M¹, Goffman D¹. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. N Engl J Med. 2020 Apr 13. doi: 10.1056/NEJMc2009316. [Epub ahead of print]
• 14 LaCourse SM, Kachikis A, Blain M, Simmons LE, Mays JA, Pattison AD, Salerno CC, McCartney SA, Kretzer NM, Resnick R, Shay RL, Savitsky LM, Curtin AC, Huebner EM, Ma KK, Delaney S, Delgado C, Schippers A, Munson J, Pottinger PS, Cohen S, Neme S, Bourassa L, Bryan A, Greninger A, Jerome KR, Roxby AC, Lokken E, Cheng E, Adams Waldorf KM, Hitti J. Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington. Clin Infect Dis. 2020 May 30:ciaa675. doi: 10.1093/cid/ciaa675. Online ahead of print.
• 15 Ochiai D, Kasuga Y, Iida M, Ikenoue S. Tanaka M.Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan. Int J Gynaecol Obstet. 2020; Jun 4 DOI: 10.1002/ijgo.13252.
• 16 Costa ML, Pacagnella RC, Guida JP, Souza RT, Charles CM, Lajos GJ, Haddad SM, Fernandes KG, Nobrega GM, Griggio TB, Pabon SL, Serruya SJ, Ribeiro-do-Valle CC, Cecatti JG. Brazilian Network for Studies on Reproductive and Perinatal Research. Call to action for a South American network to fight COVID-19 in pregnancy. Int J Gynaecol Obstet. 2020; May 15 DOI: 10.1002/ijgo.13225.
• 17 Freitas-Jesus JV, Rodrigues L, Surita FG. The Experience of Women Infected by the COVID-19 during Pregnancy in Brazil: A Qualitative Study Protocol. Repr. Health 17, 108 (2020).
• 18 Hutchison BL, Stone PR, McCowan LME, Stewart AW, Thompson JMD, Mitchell EA. A postal survey of maternal sleep in late pregnancy. BMC Pregnancy Childbirth. 2012 ;12.
• 19 Facco FL. Sleep-disordered breathing and pregnancy. Semin Perinatol. 2011; Dec; 35 (06) 335-9